Advertisement

Comorbidity pp 139-178 | Cite as

Comorbid Psychiatric Illnesses

  • Einar ThorsteinssonEmail author
  • Rhonda Brown
Chapter
First Online:
  • 225 Downloads

Abstract

Comorbidity among psychiatric illnesses is common, as is comorbidity between psychiatric and physical illnesses. Current knowledge of psychiatric comorbidity points to several possible underlying factors, notably an overlap in their definitions and symptoms; unidirectional and bidirectional causation; disordered sleep; and a range of shared risk factors. Psychiatric illness may lead to poorer self-care and sleep problems, whereas being physically ill may impact upon an individual’s psychological wellbeing. An integration of the various causal models that have been proposed to explain the comorbidities is discussed, incorporating different socio-psychological and biological factors to explain the development of depression and anxiety. These issues are detailed in the following chapter with a focus on depression. Implications for treatment are also discussed.

This is a preview of subscription content, log in to check access.

References

  1. 1.
    Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases. 1970;23(7):455–468.  https://doi.org/10.1016/0021-9681(70)90054-8.PubMedCrossRefGoogle Scholar
  2. 2.
    Richards CS, O’Hara MW, eds. The Oxford handbook of depression and comorbidity. New York, NY: Oxford University Press; 2014.Google Scholar
  3. 3.
    Eaton WW, ed. Medical and psychiatric comorbidity over the course of life. London, UK: American Psychiatric Publishing; 2007.Google Scholar
  4. 4.
    Virdis A. Hypertension and comorbidities. Cham, Switzerland: Springer; 2016.CrossRefGoogle Scholar
  5. 5.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington, DC: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  6. 6.
    Australian Bureau of Statistics. Australian social trends, March 2009. Canberra, ACT, Australia: Author; 2009. 4102.0.Google Scholar
  7. 7.
    Mental Health Foundation. Fundamental facts about mental health 2016. London, UK: Mental Health Foundation; 2016.Google Scholar
  8. 8.
    Ginzburg K, Ein-Dor T, Solomon Z. Comorbidity of posttraumatic stress disorder, anxiety and depression: A 20-year longitudinal study of war veterans. Journal of Affective Disorders. 2010;123(1):249–257.  https://doi.org/10.1016/j.jad.2009.08.006.PubMedCrossRefGoogle Scholar
  9. 9.
    Sartorius N, Üstün TB, Lecrubier Y, Wittchen H-U. Depression comorbid with anxiety: Results from the WHO study on psychological disorders in primary health care. The British Journal of Psychiatry. 1996;168(S30):38–43.  https://doi.org/10.1192/s0007125000298395.CrossRefGoogle Scholar
  10. 10.
    Brady EU, Kendall PC. Comorbidity of anxiety and depression in children and adolescents. Psychological Bulletin. 1992;111(2):244–255.  https://doi.org/10.1037/0033-2909.111.2.244.PubMedCrossRefGoogle Scholar
  11. 11.
    Cole DA, Peeke LG, Martin JM, Truglio R, Seroczynski AD. A longitudinal look at the relation between depression and anxiety in children and adolescents. Journal of Consulting and Clinical Psychology. 1998;66(3):451–460.PubMedCrossRefGoogle Scholar
  12. 12.
    Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health: The cost of co-morbidities. London, UK: The King’s Fund; 2012.Google Scholar
  13. 13.
    Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015;386(9995):743–800.  https://doi.org/10.1016/s0140-6736(15)60692-4.CrossRefGoogle Scholar
  14. 14.
    Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: Findings from the Global Burden of Disease Study 2010. PLoS Medicine. 2013;10(11):e1001547.  https://doi.org/10.1371/journal.pmed.1001547.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Pederson JL, Warkentin LM, Majumdar SR, McAlister FA. Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: A systematic review and meta‐analysis. Journal of Hospital Medicine. 2016;11(5):373–380.  https://doi.org/10.1002/jhm.2547.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Zivin K, Yosef M, Miller EM, et al. Associations between depression and all-cause and cause-specific risk of death: A retrospective cohort study in the Veterans Health Administration. Journal of Psychosomatic Research. 2015;78(4):324–331.  https://doi.org/10.1016/j.jpsychores.2015.01.014.PubMedCrossRefGoogle Scholar
  17. 17.
    Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51(1):8–19.  https://doi.org/10.1001/archpsyc.1994.03950010008002.PubMedCrossRefGoogle Scholar
  18. 18.
    Au-Yeung SK, Bradley L, Robertson AE, Shaw R, Baron-Cohen S, Cassidy S. Experience of mental health diagnosis and perceived misdiagnosis in autistic, possibly autistic and non-autistic adults. Autism. 2018.  https://doi.org/10.1177/1362361318818167.PubMedCrossRefGoogle Scholar
  19. 19.
    Hatfield TR, Brown RF, Giummarra MJ, Lenggenhager B. Autism spectrum disorder and interoception: Abnormalities in global integration? Autism. 2019;23(1):212–222.  https://doi.org/10.1177/1362361317738392.PubMedCrossRefGoogle Scholar
  20. 20.
    Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence. 2015;154:1–13.  https://doi.org/10.1016/j.drugalcdep.2015.05.031.PubMedCrossRefGoogle Scholar
  21. 21.
    Bériault M, Turgeon L, Labrosse M, et al. Comorbidity of ADHD and anxiety disorders in school-age children: Impact on sleep and response to a cognitive-behavioral treatment. Journal of Attention Disorders. 2018;22(5):414–424.  https://doi.org/10.1177/1087054715605914.PubMedCrossRefGoogle Scholar
  22. 22.
    Bryan RM, Jr. Cerebral blood flow and energy metabolism during stress. American Journal of Physiology-Heart and Circulatory Physiology. 1990;259(2):H269–H280.  https://doi.org/10.1152/ajpheart.1990.259.2.h269.CrossRefGoogle Scholar
  23. 23.
    Hull AM. Neuroimaging findings in post-traumatic stress disorder: Systematic review. British Journal of Psychiatry. 2018;181(2):102–110.  https://doi.org/10.1192/bjp.181.2.102.CrossRefGoogle Scholar
  24. 24.
    Zochil ML, Thorsteinsson EB. Exploring poor sleep, mental health, and help-seeking intention in university students. Australian Journal of Psychology. 2018;70(1):41–47.  https://doi.org/10.1111/ajpy.12160.CrossRefGoogle Scholar
  25. 25.
    Jansson-Fröjmark M, Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. Journal of Psychosomatic Research. 2008;64(4):443–449.  https://doi.org/10.1016/j.jpsychores.2007.10.016.PubMedCrossRefGoogle Scholar
  26. 26.
    Vargas I, Friedman NP, Drake CL. Vulnerability to stress-related sleep disturbance and insomnia: Investigating the link with comorbid depressive symptoms. Translational Issues in Psychological Science. 2015;1(1):57–66.  https://doi.org/10.1037/tps0000015.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Kennard BD, Mayes TL, Chahal Z, Nakonezny PA, Moorehead A, Emslie GJ. Predictors and moderators of relapse in children and adolescents with major depressive disorder. The Journal of Clinical Psychiatry. 2018;79(2).  https://doi.org/10.4088/jcp.15m10330.PubMedCrossRefGoogle Scholar
  28. 28.
    Valpiani EM, Brown RF, Thorsteinsson EB, Hine DW. Poor sleep quality mediates between depression to fatigue in a university student sample. Psychology and Education. 2011;48(1&2):59–71.Google Scholar
  29. 29.
    Thorsteinsson EB, Brown RF, Owens MT. Modelling the effects of stress, anxiety, and depression on rumination, sleep, and fatigue in a nonclinical sample. The Journal of Nervous and Mental Disease. 2019;207(5):355–359.  https://doi.org/10.1097/nmd.0000000000000973.PubMedCrossRefGoogle Scholar
  30. 30.
    Olff M, Langeland W, Gersons BP. Effects of appraisal and coping on the neuroendocrine response to extreme stress. Neuroscience & Biobehavioral Reviews. 2005;29(3):457–467.  https://doi.org/10.1016/j.neubiorev.2004.12.006.CrossRefGoogle Scholar
  31. 31.
    Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry. 1995;52(12):1048–1060.  https://doi.org/10.1001/archpsyc.1995.03950240066012.PubMedCrossRefGoogle Scholar
  32. 32.
    Orsillo SM, Batten SV. Acceptance and commitment therapy in the treatment of posttraumatic stress disorder. Behavior Modification. 2005;29(1):95–129.  https://doi.org/10.1177/0145445504270876.PubMedCrossRefGoogle Scholar
  33. 33.
    Kearney DJ, McDermott K, Malte C, Martinez M, Simpson TL. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: A randomized controlled pilot study. Journal of Clinical Psychology. 2013;69(1):14–27.PubMedCrossRefGoogle Scholar
  34. 34.
    Graham CD, Gouick J, Krahé C, Gillanders D. A systematic review of the use of acceptance and commitment therapy (ACT) in chronic disease and long-term conditions. Clinical Psychology Review. 2016;46:46–58.  https://doi.org/10.1016/j.cpr.2016.04.009.PubMedCrossRefGoogle Scholar
  35. 35.
    Strauss C, Cavanagh K, Oliver A, Pettman D. Mindfulness-based interventions for people diagnosed with a current episode of an anxiety or depressive disorder: A meta-analysis of randomised controlled trials. PLoS One. 2014;9(4):e96110.  https://doi.org/10.1371/journal.pone.0096110.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Hann KE, McCracken LM. A systematic review of randomized controlled trials of acceptance and commitment therapy for adults with chronic pain: Outcome domains, design quality, and efficacy. Journal of Contextual Behavioral Science. 2014;3(4):217–227.  https://doi.org/10.1016/j.jcbs.2014.10.001.CrossRefGoogle Scholar
  37. 37.
    Hesser H, Gustafsson T, Lundén C, et al. A randomized controlled trial of internet-delivered cognitive behavior therapy and acceptance and commitment therapy in the treatment of tinnitus. Journal of Consulting and Clinical Psychology. 2012;80(4):649–661.  https://doi.org/10.1037/a0027021.PubMedCrossRefGoogle Scholar
  38. 38.
    Swain J, Hancock K, Hainsworth C, Bowman J. Acceptance and commitment therapy in the treatment of anxiety: A systematic review. Clinical Psychology Review. 2013;33(8):965–978.  https://doi.org/10.1016/j.cpr.2013.07.002.PubMedCrossRefGoogle Scholar
  39. 39.
    Forman EM, Herbert JD, Moitra E, Yeomans PD, Geller PA. A randomized controlled effectiveness trial of acceptance and commitment therapy and cognitive therapy for anxiety and depression. Behavior Modification. 2007;31(6):772–799.  https://doi.org/10.1177/0145445507302202.PubMedCrossRefGoogle Scholar
  40. 40.
    Dalrymple KL, Fiorentino L, Politi MC, Posner D. Incorporating principles from acceptance and commitment therapy into cognitive-behavioral therapy for insomnia: A case example. Journal of Contemporary Psychotherapy. 2010;40(4):209–217.  https://doi.org/10.1007/s10879-010-9145-1.CrossRefGoogle Scholar
  41. 41.
    Wicksell RK, Kemani M, Jensen K, et al. Acceptance and commitment therapy for fibromyalgia: A randomized controlled trial. European Journal of Pain. 2013;17(4):599–611.  https://doi.org/10.1002/j.1532-2149.2012.00224.x.PubMedCrossRefGoogle Scholar
  42. 42.
    MacDonell GV, Bhullar N, Thorsteinsson EB. Depression, anxiety, and stress in partners of Australian combat veterans and military personnel: A comparison with Australian population norms. PeerJ. 2016;4:e2373.  https://doi.org/10.7717/peerj.2373.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    MacDonell GV, Thorsteinsson EB, Bhullar N, Hine DW. Psychological functioning of partners of Australian combat veterans: Contribution of veterans’ PTSD symptoms and partners’ caregiving distress. Australian Psychologist. 2014;49(5):305–312.  https://doi.org/10.1111/ap.12069.CrossRefGoogle Scholar
  44. 44.
    Lazarus RS, Folkman S. Stress, appraisal and coping. New York, NY: Springer; 1984.Google Scholar
  45. 45.
    Thomsen DK, Mehlsen MY, Christensen S, Zachariae R. Rumination—Relationship with negative mood and sleep quality. Personality and Individual Differences. 2003;34(7):1293–1301.  https://doi.org/10.1016/s0191-8869(02)00120-4.CrossRefGoogle Scholar
  46. 46.
    Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. The Journal of Endocrinology. 1999;160(1):1–12.  https://doi.org/10.1677/joe.0.1600001.PubMedCrossRefGoogle Scholar
  47. 47.
    Antonijevic I, Antonijevic I. HPA axis and sleep: Identifying subtypes of major depression. Stress. 2008;11(1):15–27.  https://doi.org/10.1080/10253890701378967.PubMedCrossRefGoogle Scholar
  48. 48.
    Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: A pilot study. Journal of Clinical Sleep Medicine. 2011;7(1):57–68.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Amiri S, Behnezhad S. Obesity and anxiety symptoms: A systematic review and meta-analysis. Neuropsychiatrie. 2019:1–18.  https://doi.org/10.1007/s40211-019-0302-9.PubMedCrossRefGoogle Scholar
  50. 50.
    Gariepy G, Nitka D, Schmitz N. The association between obesity and anxiety disorders in the population: A systematic review and meta-analysis. International Journal of Obesity. 2010;34(3):407–419.  https://doi.org/10.1038/ijo.2009.252.PubMedCrossRefGoogle Scholar
  51. 51.
    Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. New England Journal of Medicine. 2011;364(25):2392–2404.  https://doi.org/10.1056/nejmoa1014296.CrossRefPubMedGoogle Scholar
  52. 52.
    Stice E, Presnell K, Shaw H, Rohde P. Psychological and behavioral risk factors for obesity onset in adolescent girls: A prospective study. Journal of Consulting and Clinical Psychology. 2005;73(2):195–202.PubMedCrossRefGoogle Scholar
  53. 53.
    Colles SL, Dixon JB, O’Brien PE. Night eating syndrome and nocturnal snacking: Association with obesity, binge eating and psychological distress. International Journal of Obesity. 2007;31:1722–1730.  https://doi.org/10.1038/sj.ijo.0803664.PubMedCrossRefGoogle Scholar
  54. 54.
    Vander Wal JS. Night eating syndrome: A critical review of the literature. Clinical Psychology Review. 2012;32(1):49–59.  https://doi.org/10.1016/j.cpr.2011.11.001.PubMedCrossRefGoogle Scholar
  55. 55.
    Wichianson JR, Bughi SA, Unger JB, Spruijt-Metz D, Nguyen-Rodriguez ST. Perceived stress, coping and night-eating in college students. Stress and Health. 2009;25(3):235–240.  https://doi.org/10.1002/smi.1242.CrossRefGoogle Scholar
  56. 56.
    Kaye WH, Bulik CM, Thornton L, Barbarich N, Masters K, Group PFC. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. American Journal of Psychiatry. 2004;161(12):2215–2221.  https://doi.org/10.1176/appi.ajp.161.12.2215.CrossRefGoogle Scholar
  57. 57.
    Morse SA, Ciechanowski PS, Katon WJ, Hirsch IB. Isn’t this just bedtime snacking? The potential adverse effects of night-eating symptoms on treatment adherence and outcomes in patients with diabetes. Diabetes Care. 2006;29(8):1800–1804.  https://doi.org/10.2337/dc06-0315.PubMedCrossRefGoogle Scholar
  58. 58.
    Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care. 2001;24(6):1069–1078.  https://doi.org/10.2337/diacare.24.6.1069.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997;20(4):585–590.  https://doi.org/10.2337/diacare.20.4.585.PubMedCrossRefGoogle Scholar
  60. 60.
    Bretland RJ, Thorsteinsson EB. Reducing workplace burnout: The relative benefits of cardiovascular and resistance exercise. PeerJ. 2015;3:e891.  https://doi.org/10.7717/peerj.891.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. Exercise as a treatment for depression: A meta-analysis adjusting for publication bias. Journal of Psychiatric Research. 2016;77:42–51.  https://doi.org/10.1016/j.jpsychires.2016.02.023.PubMedCrossRefGoogle Scholar
  62. 62.
    Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: A meta-analysis. Psychiatry Research. 2017;249:102–108.  https://doi.org/10.1016/j.psychres.2016.12.020.PubMedCrossRefGoogle Scholar
  63. 63.
    Kelley GA, Kelley KS. Exercise and sleep: A systematic review of previous meta-analyses. Journal of Evidence-Based Medicine. 2017;10(1):26–36.  https://doi.org/10.1111/jebm.12236.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: Results of the 2003 National Sleep Foundation Sleep in America Survey. Journal of Psychosomatic Research. 2004;56(5):497–502.  https://doi.org/10.1016/j.jpsychores.2004.02.010.PubMedCrossRefGoogle Scholar
  65. 65.
    Lallukka T, Lahelma E, Rahkonen O, et al. Associations of job strain and working overtime with adverse health behaviors and obesity: Evidence from the Whitehall II Study, Helsinki Health Study, and the Japanese Civil Servants Study. Social Science & Medicine. 2008;66(8):1681–1698.  https://doi.org/10.1016/j.socscimed.2007.12.027.CrossRefGoogle Scholar
  66. 66.
    Jerstad SJ, Boutelle KN, Ness KK, Stice E. Prospective reciprocal relations between physical activity and depression in adolescent females. Journal of Consulting and Clinical Psychology. 2010;78(2):268–272.  https://doi.org/10.1037/a0018793.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Katon W, Lin EHB, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry. 2007;29(2):147–155.  https://doi.org/10.1016/j.genhosppsych.2006.11.005.PubMedCrossRefGoogle Scholar
  68. 68.
    Wu LR, Parkerson GR, Doraiswamy PM. Health perception, pain, and disability as correlates of anxiety and depression symptoms in primary care patients. Journal of the American Board of Family Medicine. 2002;15(3):183–190.Google Scholar
  69. 69.
    National Collaborating Centre for Mental Health (UK). 2 Depression in adults with a chronic physical health problem. Depression in adults with a chronic physical health problem: Treatment and management. NICE Clinical Guidelines, No. 91 ed. Leicester, UK: British Psychological Society; 2010.Google Scholar
  70. 70.
    Goldberg D. The detection and treatment of depression in the physically ill. World Psychiatry. 2010;9(1):16–20.  https://doi.org/10.1002/j.2051-5545.2010.tb00256.x.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Lerman SF, Rudich Z, Brill S, Shalev H, Shahar G. Longitudinal associations between depression, anxiety, pain, and pain-related disability in chronic pain patients. Psychosomatic Medicine. 2015;77(3):333–341.  https://doi.org/10.1097/psy.0000000000000158.PubMedCrossRefGoogle Scholar
  72. 72.
    World Health Organization. International classification of functioning, disability and health: ICF. Geneva, Switzerland: World Health Organization; 2001.Google Scholar
  73. 73.
    Kurawa SS. The impact of disability on self and society: An agenda for research on rehabilitation of disabled in Nigeria. Procedia-Social and Behavioral Sciences. 2010;5:1804–1810.  https://doi.org/10.1016/j.sbspro.2010.07.368.CrossRefGoogle Scholar
  74. 74.
    Scott K, Von Korff M, Alonso J, et al. Mental–physical co-morbidity and its relationship with disability: Results from the World Mental Health Surveys. Psychological Medicine. 2009;39(1):33–43.  https://doi.org/10.1017/s0033291708003188.PubMedCrossRefGoogle Scholar
  75. 75.
    McNicol ML, Thorsteinsson EB. Internet addiction, psychological distress, and coping responses among adolescents and adults. Cyberpsychology, Behavior, and Social Networking. 2017;20(5):296–304.  https://doi.org/10.1089/cyber.2016.0669.CrossRefGoogle Scholar
  76. 76.
    Marino C, Gini G, Vieno A, Spada MM. The associations between problematic Facebook use, psychological distress and well-being among adolescents and young adults: A systematic review and meta-analysis. Journal of Affective Disorders. 2018;226:274–281.  https://doi.org/10.1016/j.jad.2017.10.007.PubMedCrossRefGoogle Scholar
  77. 77.
    Chiungjung H. Time spent on social network sites and psychological well-being: A meta-analysis. Cyberpsychology, Behavior, and Social Networking. 2017;20(6):346–354.  https://doi.org/10.1089/cyber.2016.0758.CrossRefGoogle Scholar
  78. 78.
    Thorsteinsson EB, Davey L. Adolescents’ compulsive Internet use and depression: A longitudinal study. Open Journal of Depression. 2014;3(1):13–17.  https://doi.org/10.4236/ojd.2014.31005.CrossRefGoogle Scholar
  79. 79.
    Sveinbjornsdottir S, Thorsteinsson EB. Adolescent coping scales: A critical psychometric review. Scandinavian Journal of Psychology. 2008;49:533–548.  https://doi.org/10.1111/j.1467-9450.2008.00669.x.PubMedCrossRefGoogle Scholar
  80. 80.
    Sveinbjornsdottir S, Thorsteinsson EB, Lingam GI. Model fit and comparisons for the Measure of Adolescent Coping Strategies (MACS): Fiji, Iceland, and Australia. Journal of Pacific Rim Psychology. 2017;11:e12.  https://doi.org/10.1017/prp.2017.20.CrossRefGoogle Scholar
  81. 81.
    Sveinbjornsdottir S, Thorsteinsson EB. Psychometric properties of the Measure of Adolescent Coping Strategies (MACS). Psychology. 2014;5(2):142–147.  https://doi.org/10.4236/psych.2014.52022.CrossRefGoogle Scholar
  82. 82.
    Brown SP, Westbrook RA, Challagalla G. Good cope, bad cope: Adaptive and maladaptive coping strategies following a critical negative work event. Journal of Applied Psychology. 2005;90(4):792–798.  https://doi.org/10.1037/0021-9010.90.4.792.PubMedCrossRefGoogle Scholar
  83. 83.
    Moritz S, Jahns AK, Schröder J, et al. More adaptive versus less maladaptive coping: What is more predictive of symptom severity? Development of a new scale to investigate coping profiles across different psychopathological syndromes. Journal of Affective Disorders. 2016;191:300–307.  https://doi.org/10.1016/j.jad.2015.11.027.PubMedCrossRefGoogle Scholar
  84. 84.
    Thorsteinsson EB, Ryan S, Sveinbjornsdottir S. The mediating effects of social support and coping on the stress-depression relationship in rural and urban adolescents. Open Journal of Depression. 2013;2(1):1–6.  https://doi.org/10.4236/ojd.2013.21001.CrossRefGoogle Scholar
  85. 85.
    Thorsteinsson EB, Sveinbjornsdottir S, Dintsi M, Rooke SE. Negative life events, distress, and coping among adolescents in Botswana. Australian Journal of Educational & Developmental Psychology. 2013;13:75–86.Google Scholar
  86. 86.
    Brown RF, Valpiani EM, Tennant CC, et al. Longitudinal assessment of anxiety, depression and fatigue in people with multiple sclerosis. Psychology & Psychotherapy: Theory, Research & Practice. 2009;82:41–56.  https://doi.org/10.1348/147608308x345614.CrossRefGoogle Scholar
  87. 87.
    Wittenborn AK, Rahmandad H, Rick J, Hosseinichimeh N. Depression as a systemic syndrome: Mapping the feedback loops of major depressive disorder. Psychological Medicine. 2016;46(3):551–562.  https://doi.org/10.1017/s0033291715002044.PubMedCrossRefGoogle Scholar
  88. 88.
    Borsboom D, Cramer AOJ, Schmittmann VD, Epskamp S, Waldorp LJ. The small world of psychopathology. PLoS One. 2011;6(11):e27407.  https://doi.org/10.1371/journal.pone.0027407.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Cramer AOJ, Waldorp LJ, van der Maas HLJ, Borsboom D. Comorbidity: A network perspective. Behavioral and Brain Sciences. 2010;33(2–3):137–150.  https://doi.org/10.1017/s0140525x09991567.PubMedCrossRefGoogle Scholar
  90. 90.
    Brown RF, Thorsteinsson EB, Smithson M, Birmingham CL, Aljarallah H, Nolan C. Can body temperature dysregulation explain the co-occurrence between overweight/obesity, sleep impairment, late-night eating, and a sedentary lifestyle? Eating and Weight Disorders—Studies on Anorexia, Bulimia and Obesity. 2017;22(4):599–608.  https://doi.org/10.1007/s40519-017-0439-0.CrossRefGoogle Scholar
  91. 91.
    Bebbington PE, Brugha T, MacCarthy B, et al. The Camberwell Collaborative Depression Study I. Depressed probands: Adversity and the form of depression. The British Journal of Psychiatry. 1988;152(6):754–765.  https://doi.org/10.1192/bjp.152.6.754.PubMedCrossRefGoogle Scholar
  92. 92.
    Hammen C. Stress and depression. Annual Review of Clinical Psychology. 2005;1(1):293–319.  https://doi.org/10.1146/annurev.clinpsy.1.102803.143938.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Kujawa A, Burkhouse KL. Vulnerability to depression in youth: Advances from affective neuroscience. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2017;2(1):28–37.  https://doi.org/10.1016/j.bpsc.2016.09.006.CrossRefGoogle Scholar
  94. 94.
    Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JGF. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. European Journal of Heart Failure. 2005;7(5):803–808.  https://doi.org/10.1016/j.ejheart.2005.03.001.PubMedCrossRefGoogle Scholar
  95. 95.
    Lima MP, Longatto-Filho A, Osório FL. Predictor variables and screening protocol for depressive and anxiety disorders in cancer outpatients. PLoS One. 2016;11(3):e0149421.  https://doi.org/10.1371/journal.pone.0149421.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Reinherz HZ, Paradis AD, Giaconia RM, Stashwick CK, Fitzmaurice G. Childhood and adolescent predictors of major depression in the transition to adulthood. American Journal of Psychiatry. 2003;160(12):2141–2147.PubMedCrossRefGoogle Scholar
  97. 97.
    Anderson ER, Hope DA. A review of the tripartite model for understanding the link between anxiety and depression in youth. Clinical Psychology Review. 2008;28(2):275–287.  https://doi.org/10.1016/j.cpr.2007.05.004.PubMedCrossRefGoogle Scholar
  98. 98.
    Clark LA, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. Journal of Abnormal Psychology. 1991;100(3):316–336.PubMedCrossRefGoogle Scholar
  99. 99.
    Loh JMI, Schutte NS, Thorsteinsson EB. Be happy: The role of resilience between characteristic affect and symptoms of depression. Journal of Happiness Studies. 2014;15(5):1125–1138.  https://doi.org/10.1007/s10902-013-9467-2.CrossRefGoogle Scholar
  100. 100.
    Kawachi I, Berkman LF. Social ties and mental health. Journal of Urban Health. 2001;78(3):458–467.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Otto CM. Heartbeat: Lonely hearts. Heart. 2016;102(13):985–986.  https://doi.org/10.1136/heartjnl-2016-310034.PubMedCrossRefGoogle Scholar
  102. 102.
    Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychological Bulletin. 1985;98(2):310–357.  https://doi.org/10.1037/0033-2909.98.2.310.CrossRefPubMedGoogle Scholar
  103. 103.
    Matthews T, Danese A, Wertz J, et al. Social isolation, loneliness and depression in young adulthood: A behavioural genetic analysis. Social Psychiatry and Psychiatric Epidemiology. 2016;51(3):339–348.  https://doi.org/10.1007/s00127-016-1178-7.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Zhong C-B, Leonardelli GJ. Cold and lonely: Does social exclusion literally feel cold? Psychological Science. 2008;19(9):838–842.  https://doi.org/10.1111/j.1467-9280.2008.02165.x.PubMedCrossRefGoogle Scholar
  105. 105.
    IJzerman H, Gallucci M, Pouw WTJL, Weiβgerber SC, Van Doesum NJ, Williams KD. Cold-blooded loneliness: Social exclusion leads to lower skin temperatures. Acta Psychologica. 2012;140(3):283–288.  https://doi.org/10.1016/j.actpsy.2012.05.002.PubMedCrossRefGoogle Scholar
  106. 106.
    IJzerman H, Semin GR. The thermometer of social relations: Mapping social proximity on temperature. Psychological Science. 2009;20(10):1214–1220.  https://doi.org/10.1111/j.1467-9280.2009.02434.x.PubMedCrossRefGoogle Scholar
  107. 107.
    Seligman MEP. Learned optimism: How to change your mind and your life. Sydney, NSW, Australia: Random House; 2011.Google Scholar
  108. 108.
    Seligman MEP. Why is there so much depression today? The waxing of the individual and the waning of the commons. In: Ingram RE, ed. Contemporary psychological approaches to depression: Theory, research, and treatment. Boston, MA: Springer; 1990:1–9.Google Scholar
  109. 109.
    Seligman MEP. Learned helplessness. Annual Review of Medicine. 1972;23(1):407–412.PubMedCrossRefGoogle Scholar
  110. 110.
    Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: Implications for health. Nature Reviews Immunology. 2005;5(3):243–251.  https://doi.org/10.1038/nri1571.PubMedCrossRefGoogle Scholar
  111. 111.
    Cohen S, Tyrrell DA, Smith AP. Negative life events, perceived stress, negative affect, and susceptibility to the common cold. Journal of Personality and Social Psychology. 1993;64:131–140.PubMedCrossRefGoogle Scholar
  112. 112.
    Sheridan JF, Dobbs CM. Stress, viral pathogenesis, and immunity. In: Glaser R, Kiecolt-Glaser JK, eds. Handbook of human stress and immunity. San Diego, CA, USA: Academic Press; 1994:101–123.CrossRefGoogle Scholar
  113. 113.
    Grinde B. Is chronic fatigue syndrome caused by a rare brain infection of a common, normally benign virus? Medical Hypotheses. 2008;71(2):270–274.  https://doi.org/10.1016/j.mehy.2008.03.014.PubMedCrossRefGoogle Scholar
  114. 114.
    Doering LV, Martínez-Maza O, Vredevoe DL, Cowan MJ. Relation of depression, natural killer cell function, and infections after coronary artery bypass in women. European Journal of Cardiovascular Nursing. 2008;7(1):52–58.  https://doi.org/10.1016/j.ejcnurse.2007.07.004.PubMedCrossRefGoogle Scholar
  115. 115.
    Herbert TB, Cohen S. Stress and immunity in humans: A meta-analytic review. Psychosomatic Medicine. 1993;55:364–379.PubMedCrossRefGoogle Scholar
  116. 116.
    Kiecolt-Glaser JK, Glaser R. Depression and immune function: Central pathways to morbidity and mortality. Journal of Psychosomatic Research. 2002;53(4):873–876.  https://doi.org/10.1016/s0022-3999(02)00309-4.PubMedCrossRefGoogle Scholar
  117. 117.
    Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Archives of General Psychiatry. 2003;60(10):1009–1014.  https://doi.org/10.1001/archpsyc.60.10.1009.PubMedCrossRefGoogle Scholar
  118. 118.
    Maes M. The cytokine hypothesis of depression: Inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinology Letters. 2008;29(3):287–291.PubMedGoogle Scholar
  119. 119.
    Amsterdam JD, Winokur A, Dyson W, et al. Borna disease virus: A possible etiologic factor in human affective disorders? Archives of General Psychiatry. 1985;42(11):1093–1096.  https://doi.org/10.1001/archpsyc.1985.01790340077011.PubMedCrossRefGoogle Scholar
  120. 120.
    DeLisi LE, Nurnberger JI, Goldin LR, Simmons-Alling S, Gershon ES. Epstein-Barr virus and depression. Archives of General Psychiatry. 1986;43(8):815–816.  https://doi.org/10.1001/archpsyc.1986.01800080101016.PubMedCrossRefGoogle Scholar
  121. 121.
    Murray KO, Resnick M, Miller V. Depression after infection with West Nile virus. Emerging Infectious Diseases. 2007;13(3):479–481.PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Wang X, Zhang L, Lei Y, et al. Meta-analysis of infectious agents and depression. Scientific Reports. 2014;4:4530.  https://doi.org/10.1038/srep04530.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Rausch JL, Johnson ME, Corley KM, et al. Depressed patients have higher body temperature: 5-HT transporter long promoter region effects. Neuropsychobiology. 2003;47(3):120–127.  https://doi.org/10.1159/000070579.PubMedCrossRefGoogle Scholar
  124. 124.
    Diamond M, Kelly JP, Connor TJ. Antidepressants suppress production of the Th 1 cytokine interferon-γ, independent of monoamine transporter blockade. European Neuropsychopharmacology. 2006;16(7):481–490.  https://doi.org/10.1016/j.euroneuro.2005.11.011.PubMedCrossRefGoogle Scholar
  125. 125.
    Kubera M, Lin A-H, Kenis G, Bosmans E, van Bockstaele D, Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio. Journal of Clinical Psychopharmacology. 2001;21(2):199–206.  https://doi.org/10.1097/00004714-200104000-00012.PubMedCrossRefGoogle Scholar
  126. 126.
    Almeida OP, Flicker L, Yeap B, Alfonso H, McCaul K, Hankey GJ. Aspirin decreases the risk of depression in older men with high plasma homocysteine. Translational Psychiatry. 2012;2(8):e151.  https://doi.org/10.1038/tp.2012.79.PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Davis A, Gilhooley M, Agius M. Using non-steroidal anti-inflammatory drugs in the treatment of depression. Psychiatria Danubina. 2010;22(Suppl 1):S49–S52.PubMedGoogle Scholar
  128. 128.
    Pedersen BK. Exercise and cytokines. Immunology and Cell Biology. 2000;78(5):532–535.  https://doi.org/10.1111/j.1440-1711.2000.t01-11-.x.PubMedCrossRefGoogle Scholar
  129. 129.
    Koelsch S, Boehlig A, Hohenadel M, Nitsche I, Bauer K, Sack U. The impact of acute stress on hormones and cytokines, and how their recovery is affected by music-evoked positive mood. Scientific Reports. 2016;6:23008  https://doi.org/10.1038/srep23008.PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Brenner IKM, Castellani JW, Gabaree C, et al. Immune changes in humans during cold exposure: Effects of prior heating and exercise. Journal of Applied Physiology. 1999;87(2):699–710.PubMedCrossRefGoogle Scholar
  131. 131.
    Rhind SG, Gannon GA, Shephard RJ, Buguet A, Shek PN, Radomski MW. Cytokine induction during exertional hyperthermia is abolished by core temperature clamping: Neuroendocrine regulatory mechanisms. International Journal of Hyperthermia. 2004;20(5):503–516.  https://doi.org/10.1080/02656730410001670651.PubMedCrossRefGoogle Scholar
  132. 132.
    DuBose DA, Balcius J, Morehouse D. Heat stress and/or endotoxin effects on cytokine expression by human whole blood. Shock. 2002;17(3):217–221.PubMedCrossRefGoogle Scholar
  133. 133.
    Leon LR. Heat stroke and cytokines. Progress in Brain Research. 2007;162:481–524.  https://doi.org/10.1016/s0079-6123(06)62024-4.PubMedCrossRefGoogle Scholar
  134. 134.
    Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP. Exercise and the stress system. Hormones. 2005;4(2):73–89.PubMedGoogle Scholar
  135. 135.
    Liao W, Wang Z, Zhang X, et al. Cerebral blood flow changes in remitted early-and late-onset depression patients. Oncotarget. 2017;8(44):76214–76222.  https://doi.org/10.18632/oncotarget.19185.PubMedPubMedCentralCrossRefGoogle Scholar
  136. 136.
    Su L, Cai Y, Xu Y, Dutt A, Shi S, Bramon E. Cerebral metabolism in major depressive disorder: A voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry. 2014;14(1):321.  https://doi.org/10.1186/s12888-014-0321-9.PubMedPubMedCentralCrossRefGoogle Scholar
  137. 137.
    Manji HK, Drevets WC, Charney DS. The cellular neurobiology of depression. Nature Medicine. 2001;7(5):541–547.  https://doi.org/10.1038/87865.PubMedCrossRefGoogle Scholar
  138. 138.
    Öngür D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Science of the United States of America. 1998;95(22):13290–13295.  https://doi.org/10.1073/pnas.95.22.13290.CrossRefGoogle Scholar
  139. 139.
    Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry. 1999;45(9):1085–1098.  https://doi.org/10.1016/s0006-3223(99)00041-4.PubMedCrossRefGoogle Scholar
  140. 140.
    Morris A, Zhao L, Ahmed Y, et al. Association between depression and inflammation–differences by race and sex: The META-Health study. Psychosomatic Medicine. 2011;73(6):462–468.  https://doi.org/10.1097/psy.0b013e318222379c.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biological Psychiatry. 2010;67(5):446–457.  https://doi.org/10.1016/j.biopsych.2009.09.033.PubMedCrossRefGoogle Scholar
  142. 142.
    Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain, Behavior, and Immunity. 2015;49:206–215.  https://doi.org/10.1016/j.bbi.2015.06.001..PubMedPubMedCentralCrossRefGoogle Scholar
  143. 143.
    Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology. 2006;27(1):24–31.  https://doi.org/10.1016/j.it.2005.11.006.PubMedCrossRefGoogle Scholar
  144. 144.
    Udina M, Hidalgo D, Navinés R, et al. Prophylactic antidepressant treatment of interferon-induced depression in chronic hepatitis C: A systematic review and meta-analysis. The Journal of Clinical Psychiatry. 2014;75(10):e1113–e1121.  https://doi.org/10.4088/jcp.13r08800.PubMedCrossRefGoogle Scholar
  145. 145.
    Engler H, Brendt P, Wischermann J, et al. Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: Association with depressive symptoms. Molecular Psychiatry. 2017;22(10):1448–1454.  https://doi.org/10.1038/mp.2016.264.PubMedCrossRefGoogle Scholar
  146. 146.
    Strawbridge R, Arnone D, Danese A, Papadopoulos A, Vives AH, Cleare AJ. Inflammation and clinical response to treatment in depression: A meta-analysis. European Neuropsychopharmacology. 2015;25(10):1532–1543.  https://doi.org/10.1016/j.euroneuro.2015.06.007.PubMedCrossRefGoogle Scholar
  147. 147.
    Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clinical Microbiology Reviews. 2009;22(2):240–273.  https://doi.org/10.1128/cmr.00046-08.PubMedPubMedCentralCrossRefGoogle Scholar
  148. 148.
    McDonald DR, Levy O. Innate immunity. Clinical immunology: Principles and practice. 5th ed. Amsterdam, The Netherlands: Elsevier; 2019:39–53. e31.Google Scholar
  149. 149.
    Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. The Journal of Clinical Investigation. 2008;118(11):3537–3545.  https://doi.org/10.1172/jci36389.PubMedPubMedCentralCrossRefGoogle Scholar
  150. 150.
    McClane SJ, Rombeau JL. Cytokines and inflammatory bowel disease: A review. Journal of Parenteral and Enteral Nutrition. 1999;23:S20–S24.  https://doi.org/10.1177/014860719902300506.PubMedCrossRefGoogle Scholar
  151. 151.
    Mehra VC, Ramgolam VS, Bender JR. Cytokines and cardiovascular disease. Journal of Leukocyte Biology. 2005;78(4):805–818.  https://doi.org/10.1189/jlb.0405182.PubMedCrossRefGoogle Scholar
  152. 152.
    King GL. The role of inflammatory cytokines in diabetes and its complications. Journal of Periodontology. 2008;79:1527–1534.  https://doi.org/10.1902/jop.2008.080246.PubMedCrossRefGoogle Scholar
  153. 153.
    Upthegrove R, Manzanares-Teson N, Barnes NM. Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis. Schizophrenia Research. 2014;155(1–3):101–108.  https://doi.org/10.1016/j.schres.2014.03.005.PubMedCrossRefGoogle Scholar
  154. 154.
    Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MNS, Teixeira AL. A cytokine study of adult patients with obsessive-compulsive disorder. Comprehensive Psychiatry. 2012;53(6):797–804.  https://doi.org/10.1016/j.comppsych.2011.12.007.PubMedCrossRefGoogle Scholar
  155. 155.
    Maes M. The immunoregulatory effects of antidepressants. Human Psychopharmacology: Clinical and Experimental. 2001;16(1):95–103.  https://doi.org/10.1002/hup.191.CrossRefGoogle Scholar
  156. 156.
    Maes M, Kenis G, Kubera M, De Baets M, Steinbusch H, Bosmans E. The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway. International Immunopharmacology. 2005;5(3):609–618.  https://doi.org/10.1016/j.intimp.2004.11.008.PubMedCrossRefGoogle Scholar
  157. 157.
    Mazzoli R, Pessione E. The neuro-endocrinological role of microbial glutamate and GABA signaling. Frontiers in Microbiology. 2016;7:e1934.  https://doi.org/10.3389/fmicb.2016.01934.CrossRefGoogle Scholar
  158. 158.
    Li Q, Han Y, Dy ABC, Hagerman RJ. The gut microbiota and autism spectrum disorders. Front in Cellular Neuroscience. 2017;11:120.  https://doi.org/10.3389/fncel.2017.00120.CrossRefGoogle Scholar
  159. 159.
    Salman FT, Buyruk MN, Gürler N, Celik A. The effect of surgical trauma on the bacterial translocation from the gut. Journal of Pediatric Surgery. 1992;27(7):802–804.  https://doi.org/10.1016/0022-3468(92)90368-h.PubMedCrossRefGoogle Scholar
  160. 160.
    Berg RD, Wommack E, Deitch EA. Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Archives of Surgery. 1988;123(11):1359–1364.  https://doi.org/10.1001/archsurg.1988.01400350073011.PubMedCrossRefGoogle Scholar
  161. 161.
    Maes M, Kubera M, Leunis J-C. The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinology Letters. 2008;29(1):117–124.PubMedGoogle Scholar
  162. 162.
    Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders. Frontiers in Cellular Neuroscience. 2015;9:e392.  https://doi.org/10.3389/fncel.2015.00392.CrossRefGoogle Scholar
  163. 163.
    Ando T, Brown RF, Berg RD, Dunn AJ. Bacterial translocation can increase plasma corticosterone and brain catecholamine and indoleamine metabolism. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2000;279(6):R2164–R2172.  https://doi.org/10.1152/ajpregu.2000.279.6.r2164.PubMedCrossRefGoogle Scholar
  164. 164.
    Dunn AJ, Ando T, Brown RF, Berg RD. HPA axis activation and neurochemical responses to bacterial translocation from the gastrointestinal tract. Annals of the New York Academy of Sciences. 2003;992(1):21–29.  https://doi.org/10.1111/j.1749-6632.2003.tb03134.x.PubMedCrossRefGoogle Scholar
  165. 165.
    Walker EA, Katon WJ, Jemelka RP, Roy-Byrne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. The American Journal of Medicine. 1992;92(1):S26–S30.  https://doi.org/10.1016/0002-9343(92)90133-v.CrossRefGoogle Scholar
  166. 166.
    Bener A, Dafeeah EE. Impact of depression and anxiety disorders on gastrointestinal symptoms and its prevalence in the general population. Biomedical Research. 2011;22(4):407–415.Google Scholar
  167. 167.
    Haug TT, Mykletun A, Dahl AA. The prevalence of nausea in the community: Psychological, social and somatic factors. General Hospital Psychiatry. 2002;24(2):81–86.  https://doi.org/10.1016/s0163-8343(01)00184-0.PubMedCrossRefGoogle Scholar
  168. 168.
    Goldsmith G, Levin JS. Effect of sleep quality on symptoms of irritable bowel syndrome. Digestive Diseases and Sciences. 1993;38(10):1809–1814.  https://doi.org/10.1007/bf01296103.PubMedCrossRefGoogle Scholar
  169. 169.
    Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: More than a gut feeling. Schizophrenia Research. 2016;176(1):23–35.  https://doi.org/10.1016/j.schres.2014.06.027.PubMedCrossRefGoogle Scholar
  170. 170.
    Nermani K, Ghomi RH, McCormick B, Fan X. Schizophrenia and the gut–brain axis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2015;56:155–160.  https://doi.org/10.1016/j.pnpbp.2014.08.018.CrossRefGoogle Scholar
  171. 171.
    Nguyen TT, Kosciolek T, Eyler LT, Knight R, Jeste DV. Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. Journal of Psychiatric Research. 2018;99:50–61.  https://doi.org/10.1016/j.jpsychires.2018.01.013.PubMedPubMedCentralCrossRefGoogle Scholar
  172. 172.
    Krajmalnik-Brown R, Lozupone C, Kang D-W, Adams JB. Gut bacteria in children with autism spectrum disorders: Challenges and promise of studying how a complex community influences a complex disease. Microbial Ecology in Health and Disease. 2015;26(1):26914.  https://doi.org/10.3402/mehd.v26.26914.PubMedCrossRefGoogle Scholar
  173. 173.
    Luna RA, Foster JA. Gut brain axis: Diet microbiota interactions and implications for modulation of anxiety and depression. Current Opinion in Biotechnology. 2015;32:35–41.  https://doi.org/10.1016/j.copbio.2014.10.007.PubMedCrossRefGoogle Scholar
  174. 174.
    Pirbaglou M, Katz J, de Souza RJ, Stearns JC, Motamed M, Ritvo P. Probiotic supplementation can positively affect anxiety and depressive symptoms: A systematic review of randomized controlled trials. Nutrition Research. 2016;36(9):889–898.  https://doi.org/10.1016/j.nutres.2016.06.009.PubMedCrossRefGoogle Scholar
  175. 175.
    Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32(3):315–320.  https://doi.org/10.1016/j.nut.2015.09.003.PubMedCrossRefGoogle Scholar
  176. 176.
    Dickerson FB, Stallings C, Origoni A, et al. Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: A randomized, placebo-controlled trial. The Primary Care Companion for CNS Disorders. 2014;16(1).  https://doi.org/10.4088/pcc.13m01579.
  177. 177.
    Sanchez-Villegas A, Henriquez P, Bes-Rastrollo M, Doreste J. Mediterranean diet and depression. Public Health Nutrition. 2006;9(8A):1104–1109.  https://doi.org/10.1017/s1368980007668578.PubMedCrossRefGoogle Scholar
  178. 178.
    Sanchez-Villegas A, Martínez-González MA. Diet, a new target to prevent depression? BMC Medicine. 2013;11(1):3.  https://doi.org/10.1186/1741-7015-11-3.PubMedPubMedCentralCrossRefGoogle Scholar
  179. 179.
    Schmittmann VD, Cramer AOJ, Waldorp LJ, Epskamp S, Kievit RA, Borsboom D. Deconstructing the construct: A network perspective on psychological phenomena. New Ideas in Psychology. 2013;31(1):43–53.  https://doi.org/10.1016/j.newideapsych.2011.02.007.CrossRefGoogle Scholar
  180. 180.
    Bicakova-Rocher A, Gorceix A, Reinberg A, Ashkenazi II, Ticher A. Temperature rhythm of patients with major affective disorders: Reduced orcadian period length. Chronobiology International. 1996;13(1):47–57.  https://doi.org/10.3109/07420529609040841.PubMedCrossRefGoogle Scholar
  181. 181.
    Nikitopoulou G, Crammer JL. Change in diurnal temperature rhythm in manic-depressive illness. British Medical Journal. 1976;1(6021):1311–1314.  https://doi.org/10.1136/bmj.1.6021.1311.PubMedPubMedCentralCrossRefGoogle Scholar
  182. 182.
    Murray G, Allen NB, Trinder J. Mood and the circadian system: Investigation of a circadian component in positive affect. Chronobiology International. 2002;19(6):1151–1169.  https://doi.org/10.1081/cbi-120015956.PubMedCrossRefGoogle Scholar
  183. 183.
    Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: Efficacy, protocol, safety, and side effects. CNS Spectrums. 2005;10(8):647–663.  https://doi.org/10.1017/s1092852900019611.PubMedCrossRefGoogle Scholar
  184. 184.
    Gammack JK. Light therapy for insomnia in older adults. Clinics in Geriatric Medicine. 2008;24(1):139–149.  https://doi.org/10.1016/j.cger.2007.08.013.PubMedCrossRefGoogle Scholar
  185. 185.
    Chesson AL, Jr., Littner M, Davila D, et al. Practice parameters for the use of light therapy in the treatment of sleep disorders. Sleep. 1999;22(5):641–660.  https://doi.org/10.1093/sleep/22.5.641.PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2020

Authors and Affiliations

  1. 1.University of New EnglandArmidaleAustralia
  2. 2.Australian National UniversityCanberraAustralia

Personalised recommendations

Cite chapter

Buy options